Medistim ASA

OL:MEDI Norway Medical Devices
Market Cap
$331.98 Million
Nkr3.78 Billion NOK
Market Cap Rank
#14282 Global
#43 in Norway
Share Price
Nkr207.00
Change (1 day)
-1.43%
52-Week Range
Nkr159.00 - Nkr284.00
All Time High
Nkr377.47
About

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more

Medistim ASA (MEDI) - Total Liabilities

Latest total liabilities as of June 2025: Nkr151.23 Million NOK

Based on the latest financial reports, Medistim ASA (MEDI) has total liabilities worth Nkr151.23 Million NOK as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Medistim ASA - Total Liabilities Trend (2004–2024)

This chart illustrates how Medistim ASA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Medistim ASA Competitors by Total Liabilities

The table below lists competitors of Medistim ASA ranked by their total liabilities.

Company Country Total Liabilities
BCPG Public Company Limited
BK:BCPG
Thailand ฿29.15 Billion
Akcansa Cimento Sanayi ve Ticaret AS
IS:AKCNS
Turkey TL9.02 Billion
ToolGen Inc.
KQ:199800
Korea ₩14.88 Billion
Inzone Group Co Ltd
SHG:600858
China CN¥8.77 Billion
Hefei Gocom Information Technology Co Ltd
SHG:688367
China CN¥144.72 Million
Alico Inc
NASDAQ:ALCO
USA $90.50 Million
Lanzhou Foci Pharmaceutical Co Ltd
SHE:002644
China CN¥678.01 Million

Liability Composition Analysis (2004–2024)

This chart breaks down Medistim ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medistim ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medistim ASA (2004–2024)

The table below shows the annual total liabilities of Medistim ASA from 2004 to 2024.

Year Total Liabilities Change
2024-12-31 Nkr138.36 Million +28.37%
2023-12-31 Nkr107.78 Million -6.25%
2022-12-31 Nkr114.97 Million +18.29%
2021-12-31 Nkr97.19 Million +9.24%
2020-12-31 Nkr88.97 Million -10.35%
2019-12-31 Nkr99.25 Million +57.84%
2018-12-31 Nkr62.88 Million -7.64%
2017-12-31 Nkr68.08 Million +35.23%
2016-12-31 Nkr50.34 Million -19.15%
2015-12-31 Nkr62.27 Million -3.29%
2014-12-31 Nkr64.39 Million +37.72%
2013-12-31 Nkr46.76 Million +27.41%
2012-12-31 Nkr36.70 Million -14.14%
2011-12-31 Nkr42.74 Million +12.15%
2010-12-31 Nkr38.11 Million -3.11%
2009-12-31 Nkr39.33 Million -21.21%
2008-12-31 Nkr49.92 Million +42.82%
2007-12-31 Nkr34.96 Million -22.47%
2006-12-31 Nkr45.09 Million +156.44%
2005-12-31 Nkr17.58 Million +40.95%
2004-12-31 Nkr12.47 Million --